At NINGBO INNO PHARMCHEM CO.,LTD., we understand the intricate needs of the pharmaceutical industry. Today, we shine a spotlight on a critical compound that is making significant waves in ophthalmic drug development: (S)-Benzyl 2-amino-3-(3-(methylsulfonyl)phenyl)propanoate Hydrochloride, identified by its CAS number 1194550-59-8.

This sophisticated molecule serves as a vital pharmaceutical intermediate, most notably in the synthesis of Lifitegrast. Lifitegrast is a groundbreaking LFA-1 (Lymphocyte Function-Associated Antigen-1) antagonist, a class of drugs that modulate immune responses. Its primary application is in the treatment of dry eye syndrome, a chronic condition affecting millions worldwide. The effectiveness of Lifitegrast hinges on the precise chemical structure and stereochemistry of its precursors, making the quality and purity of intermediates like our product absolutely paramount.

The specific role of (S)-Benzyl 2-amino-3-(3-(methylsulfonyl)phenyl)propanoate Hydrochloride lies in its ability to precisely integrate into the larger Lifitegrast molecule, ensuring the final drug product has the correct three-dimensional structure required for optimal binding to its target. This level of specificity is crucial for therapeutic efficacy and minimizing off-target effects. Researchers frequently inquire about what is benzyl (S)-2-amino-3-(3-(methylsulfonyl)phenyl)propanoate used for, and the answer is clear: it is a cornerstone for developing advanced ophthalmic solutions.

For pharmaceutical manufacturers and R&D departments, securing a reliable supply of high-quality intermediates is essential. This is where understanding the importance of a trusted lifitegrast intermediate supplier china becomes apparent. NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing pharmaceutical-grade intermediates that meet stringent international quality standards, ensuring consistency and purity for every batch. Our dedication to rigorous quality control directly supports the successful synthesis of lifitegrast intermediate and the subsequent production of life-changing medications.

The chemical industry continuously seeks to optimize synthesis routes to improve efficiency and reduce costs. The development of robust methods for the synthesis of Lifitegrast intermediate is an ongoing area of research, and our company actively contributes to these advancements by ensuring the availability of highly pure starting materials. The focus on obtaining the correct (S)-benzyl 2-amino-3-(3-(methylsulfonyl)phenyl)propanoate Hydrochloride price that reflects its high quality and importance is a testament to its value in the pharmaceutical supply chain.

In conclusion, (S)-Benzyl 2-amino-3-(3-(methylsulfonyl)phenyl)propanoate Hydrochloride is more than just a chemical compound; it is a key enabler of therapeutic innovation. Its role in Lifitegrast synthesis underscores the critical importance of specialized pharmaceutical intermediates in bringing effective treatments to patients suffering from conditions like dry eye. At NINGBO INNO PHARMCHEM CO.,LTD., we are proud to be a part of this vital process, supporting the global effort to improve eye health through advanced pharmaceutical chemistry.